Centers for Disease Control and Prevention Archives
Vaccine effectiveness research continues to grow
Jan. 26, 2023—Vanderbilt's participation in vaccine effectiveness research continues to grow, with the Medical Center playing critical roles in several networks focused on surveillance of vaccine-preventable respiratory diseases.
Study to explore COVID’s impact on essential workers
Jan. 26, 2023—Vanderbilt researchers are inviting non-health care essential workers to participate in a study to better understand how they continue to be impacted by COVID-19.
Flu season came early, hit hard in Tennessee
Dec. 21, 2022—Flu season came a month early this year in Tennessee and hit hard, disproportionately affecting children, according to Epidemic Intelligence Service (EIS) data gathered by the Centers for Disease Control and Prevention (CDC), Tennessee Department of Health and Vanderbilt University Medical Center.
Pushing (anti-overdose) drugs
May. 23, 2022—An automated alert to encourage clinicians to coprescribe naloxone for patients at risk of opioid overdose increased naloxone prescriptions per opioid prescription 16-fold.
VU, VUMC research funding surpasses $1 billion
Apr. 6, 2022—Vanderbilt University and Vanderbilt University Medical Center received more than $1 billion in research funding awarded from external organizations in 2021.
VUMC awarded CDC funding to combat antimicrobial resistance, infectious diseases
Dec. 7, 2021—Vanderbilt has partnered with the CDC to combat the crisis of antimicrobial resistance and other healthcare threats through a newly created Global Action in Healthcare Network (GAIHN).
VKC data shows increase in autism spectrum disorder prevalence, provides new data on 4-year-olds
Dec. 2, 2021—Vanderbilt Kennedy Center (VKC) researchers are seeing an increase in the number of children in Tennessee with autism spectrum disorder (ASD).
Heparin, platelets discouraged as treatment for blood clots after COVID vaccine
May. 12, 2021—Heparin and platelets are discouraged as treatment for patients who develop blood clots in the brain and low platelet counts 6-15 days after receiving Johnson & Johnson’s Janssen COVID-19 vaccine, following a clinical investigation review of 12 U.S. cases conducted by the CDC and institutions including Vanderbilt University Medical Center.
Malin appointed to CDC’s Board of Scientific Counselors
Apr. 29, 2021—Bradley Malin, PhD, professor of Biomedical Informatics, Biostatistics and Computer Science, has been appointed to the Board of Scientific Counselors (BSC) of the National Center for Health Statistics (NCHS) of the U.S. Centers for Disease Control and Prevention (CDC) through 2024.
Study shows eating at restaurants may increase COVID-19 risk
Sep. 11, 2020—Eating at dine-in restaurants appears to increase the risk of becoming sick with COVID-19, according to a recent study by the Centers for Disease Control and Prevention (CDC) and Vanderbilt University Medical Center.
ID of ‘stomach flu’ culprit
Aug. 6, 2020—Identifying the norovirus genotypes associated with more severe infections in children could guide strain selection for candidate norovirus vaccines.
American Airlines boosts travelers’ peace of mind with VUMC expertise
Jun. 26, 2020—American Airlines has created a new Travel Health Advisory Panel that includes Vanderbilt University Medical Center infectious disease experts to advise on health and cleaning matters as travelers return over the summer.
